Lutropin Alfa 相關新聞

← 返回新聞總覽


Lutropin Alfa 目前有 0 則相關新聞報導,預測適應症 20 個。

本頁整合 Lutropin Alfa 的 AI 預測適應症與最新健康新聞,橘色標示的適應症表示近期有相關新聞報導。
藥物資訊
  • 原適應症:Luveris in association with a follicle-stimulating-hormone (FSH) preparation is recommended for the stimulation of follicular development in women with severe luteinising-hormone (LH) and FSH...
  • 證據等級:L5
  • 預測適應症(20 個):
    • postural orthostatic tachycardia syndrome(97.0%)
    • peptic esophagitis(97.0%)
    • trichotillomania(96.3%)
    • Raynaud disease(95.7%)
    • duodenal ulcer (disease)(95.6%)
    • Tourette syndrome(95.2%)
    • esophageal disease(94.9%)
    • sinoatrial block(94.9%)
    • multiple endocrine neoplasia(94.9%)
    • duodenogastric reflux(94.6%)
    • duodenal obstruction(94.4%)
    • sinoatrial node disease(94.2%)
    • non-syndromic esophageal malformation(93.5%)
    • amenorrhea (disease)(93.1%)
    • active peptic ulcer disease(92.8%)
    • esophageal ulcer(92.7%)
    • progressive familial heart block(92.6%)
    • adrenal gland hyperfunction(92.4%)
    • gastrojejunal ulcer(92.4%)
    • peptic ulcer perforation(92.4%)

查看完整藥物報告 →

相關新聞(0 則)

目前沒有相關新聞報導。當有新聞提到此藥物時,系統會自動收集並顯示在這裡。

免責聲明:本頁新聞由系統自動收集,僅供研究參考,不構成醫療建議。

Copyright © 2026 EuTxGNN Project. For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.